Clinical Trial: Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Acute Ischemic Stroke
Study Type: Interventional
Official Title: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-Finding, Multi-center Study to Assess the Efficacy and Safety of Dengzhanxixin Injection in Patients With Acute Ischemic Stroke Receiving
Brief Summary:
To assess the Efficacy and Safety of Dengzhanxixin Injection in Patients With Acute Ischemic Stroke Receiving Reperfusion Therapy.
Read more